U.S. Markets closed

Palatin Technologies, Inc. (PTN)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.39-0.00 (-0.03%)
At close: 3:59PM EDT

0.39 -0.00 (-0.77%)
After hours: 4:57PM EDT

People also watch
RNNHEBMSTXCVMCYTR
  • S
    S.P.
    S.P.
    Yahoo still has a $3.83 1-year price target on this. That would be a 10-bagger and a market cap of half a billion dollars.
    Too funny.
  • S
    Sender
    Sender
    4 years later and still under water, bad stock to buy I wish I had never bought this pcs of #$%$.
  • U
    Uday
    Uday
    One of the sh%t stock, screwed so many small investors
  • M
    Mr. Big
    Mr. Big
    Volume drying up with movements of half a cent or less. Could be near the end of the line now. Get the defibrillators!
  • R
    Ron
    Ron
    Loser. This is pure #$%$
  • k
    kevin
    kevin
    EU commercial & development partnership 2H2017
     EU phase 3 trial start 1H2018
     EU phase 3 data 2H2019
     EU submission to EMA 1H2020
  • B
    Bob
    Bob
    where are those posters who were yelping 2.00 5.00 an acquisition target.. buy big boy stocks
  • K
    Kevin
    Kevin
    I have been in this stock for a very long time, before the reverse split. Historically this stock has sucked for 10 years and will continue to suck. Phil, Phil are you still out there? Do you still think this is a strong buy? I dare you to respond.
  • S
    Sender
    Sender
    I have held this stock for over two years and still haven't made a dime what a pcs of #$%$
  • R
    Ron
    Ron
    10,000th of a Penney it's trading. Your guys will be rich.
  • B
    Believer
    Believer
    Dang. And I thought we had a bonerfied rally going ... Oh well.
  • U
    Uday
    Uday
    This sh#t stock screwed lot of investors like me who got struck at $0.65 levels.
  • R
    Ron
    Ron
    Just love the insider purchases. Too funny.
  • Y
    Yfest
    Yfest
    Not a peep from AMAG analyst on Brem. Here's JPMorgan:

    Remain cautious on AMAG shares, but closely watching Intrarosa uptake. While we acknowledge that Makena may not face the immediate sharp decline typical with multi-player generic competition in February, we see multiple events that would need to play out to begin to diversify revenues away from Makena. Along these lines, we see the story of AMAG shares ultimately hinging on commercial execution beginning with the Intrarosa launch this fall, the successful on-time approval and conversion of SC Makena next spring, and growth/sales trajectory for Feraheme on the back of the IDA label expansion. While these represent multiple potential opportunities, we continue to see the durability of the Makena franchise hinging on the pace/number of generics that enter and see an on-time approval for auto-injector as a key de-risking event for the stock whether Intrarosa launches quickly or not.

    Any more fake news Kevin?
  • A
    Ashley
    Ashley
    Okay, broke under 40, let's see if it closes there. If you have the patience to wait 2 years, media hype will create a little rally, MAYBE...or maybe not. Only for gambling money though. Not the type of stock to be considered an investment as this could go to single digits in a heartbeat.
  • M
    Mackenzie
    Mackenzie
    Is it time to make a move on PTN? Yo you should really check out Awe.Som.e.Sto-cks., they seem on point with their stocks.
  • c
    charlie
    charlie
    That was an interesting report by Amag. Barely a peep, must be they are holding this close for some reason. May be time to purchase Amag. They did say they expended $16 million on NDA costs via PTN????Hmmmmmmmm
  • M
    Mr. Big
    Mr. Big
    These daily $0.0003 moves are a pathetic joke. This hapless mess has been a loser for going on two decades now. Hard to believe there are any longs left here after taking it in the kiester repeatedly by this sham company.
  • A
    Ashley
    Ashley
    I am hereby presenting Ron with a Rhodes Scholarship, for his unique genius discovery that PTN is a horrible stock. Furthermore, we should collectively nominate him for a nobel peace prize in stock analytics, for sharing this wonderful new insight with the board!!! May I ask you Ron, how you deduced so brilliantly that this was a horrible stock, when everything about it has been so spectacular for the past 2 decades??? How did you ever figure out what has clearly eluded the entire investment world for nearly a quarter century???
  • A
    Ashley
    Ashley
    Omg...believer...check out the BUTTHURT reply Ron left for you... or probably ME actually...i can't stop LAUGHING!! OMG, i..i.. I just CANT!! 🤣🤣🤣